BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16149617)

  • 1. [Tissue polypeptide antigen (TPA)].
    Sugiyama Y; Kawaguchi Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():705-7. PubMed ID: 16149617
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum tissue polypeptide antigen (TPA): monoclonal or polyclonal radio-immunometric assay for the follow-up of bladder cancer.
    Bennink R; Van Poppel H; Billen J; Decoster M; Baert L; Mortelmans L; Blanckaert N
    Anticancer Res; 1999; 19(4A):2609-13. PubMed ID: 10470203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CA19-9].
    Odagiri E
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():642-4. PubMed ID: 16149600
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of tissue polypeptide antigen as a tumor marker].
    Takahashi H; Kameda H
    Nihon Rinsho; 1990 Feb; 48 Suppl():928-30. PubMed ID: 2355634
    [No Abstract]   [Full Text] [Related]  

  • 5. [Basic fetoprotein (BFP)].
    Ishii M; Seino Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():629-31. PubMed ID: 16149596
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LIA-mat in urinary bladder cancer.
    Stieber P; Schmeller N; Schambeck C; Hofmann K; Reiter W; Hasholzner U; Fateh-Moghadam A
    Anticancer Res; 1996; 16(6B):3793-8. PubMed ID: 9042259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive acid protein (IAP)].
    Ikeda H
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():711-2. PubMed ID: 16149619
    [No Abstract]   [Full Text] [Related]  

  • 8. Tissue polypeptide antigen in bronchogenic carcinoma.
    Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
    Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [NCC-ST-439].
    Sugano K
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():681-3. PubMed ID: 16149610
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic value of tissue polypeptide antigen (TPA) plasma levels in patients with malignant salivary gland tumors.
    Tanany H; Ezz M; Yassin S
    Egypt Dent J; 1993 Jul; 39(3):505-6. PubMed ID: 9590978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum tissue polypeptide antigen (TPA) as tumor marker for bladder cancer.
    van Poppel H; Billen J; Goethuys H; Elgamal AA; Gerits M; Mortelmans L; Blanckaert N; Baert L
    Anticancer Res; 1996; 16(4B):2205-7. PubMed ID: 8694544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tissue polypeptide antigen and carcinoembryonic antigen in bladder neoplasms].
    Krajewska B; Stelmach W; Lutz W; Matych J
    Med Pr; 1995; 46(1):7-16. PubMed ID: 9732842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [2-->6 Sialyl Le(a) antigen].
    Miyazaki K; Kannagi R
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():663-8. PubMed ID: 16149606
    [No Abstract]   [Full Text] [Related]  

  • 14. Tissue polypeptide antigen (TPA) in comparison with mutations of tumour suppressor gene P53 (TP53) in patients with bladder cancer.
    Ecke TH; Lenk SV; Schlechte HH; Loening SA
    Anticancer Res; 2003; 23(2A):957-62. PubMed ID: 12820330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [SLX (sialyl SSEA-1, sialyl Le(x)-i)].
    Kannagi R; Izawa M; Koike T
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():675-80. PubMed ID: 16149609
    [No Abstract]   [Full Text] [Related]  

  • 16. [Squamous cell carcinoma antigen].
    Nawata S; Sugino N; Kato H
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():684-6. PubMed ID: 16149611
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neuron specific enolase].
    Odagiri E
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():717-9. PubMed ID: 16149621
    [No Abstract]   [Full Text] [Related]  

  • 18. [Polyamine and ornithine decarboxylase].
    Kubota S
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():744-7. PubMed ID: 16149629
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
    Pan QR; Zhang X; Xu ZF; Zheng S
    Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
    Buccheri G; Ferrigno D
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.